August 01, 2012
Intellipharmaceutics Corp. has settled patent infringement claims brought by AstraZeneca Pharmaceuticals LP over plans to market a generic version of anti-psychotic drug Seroquel XR, agreeing Monday to delay the launch of its version and admit the legitimacy of AstraZeneca's Seroquel patents.